Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Harrison, Lindsay B
ARGON-2, NCT04378010 / 2019-003876-38: A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH	Terminated	2b	98	Europe, Canada, US, RoW	EDP-305 1.5 mg, EDP-305, EDP-305 2 mg, Placebo	Enanta Pharmaceuticals, Inc, Enanta Pharmaceuticals, Inc.	Non-Alcoholic Steatohepatitis	10/21	11/21
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®	Completed	N/A	244	US	MiniMed 780G System	Medtronic Diabetes, Eli Lilly and Company	Type 1 Diabetes	01/24	01/24
Shelton, Lauren
OPTI-2, NCT06238778: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec	Recruiting	2	230	US	HDV-Lispro, HDV-L, Lispro, LIS	Diasome Pharmaceuticlas, Inc.	Diabetes Mellitus, Type 1	06/25	12/25
NCT05325294: Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®	Completed	N/A	244	US	MiniMed 780G System	Medtronic Diabetes, Eli Lilly and Company	Type 1 Diabetes	01/24	01/24